Nilay Krishna

Dr, Department of Obstetrics and Gynaecology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India

Publications

  • Review Article   
    Role of 2-DG in Fighting COVID-19
    Author(s): Nilay Krishna* and Abhishek Ingole

    A new respiratory pathogen, SARS-CoV-2, is now a global hobby and has been declared a global public health emergency. Invasion of SARS-CoV-2 is mediated by viral spike glycoprotein (S2). The virus is then conserved from the host cell machine by using the number one viral proteases 3CLpro and NSP15 endoribonuclease. In the popular context, a review of modified virulence factors with the help of a unique chemotherapeutic drug as a promising new anti-cancer drug and a new 2DG analog dose adjuvant called this review. The causes of the modern COVID-19 pandemic have been extensively studied to analyses its pathophysiology and its effects on metabolic tools in human cells. Glycolysis copies and spreads the virus as energy. Therefore, interrupting viral replication helps reduce viral replication. The idea behind reusing it in COVID-19 is that 2DG can be combine.. Read More»

    Abstract HTML PDF